◀ Back to MAPK14

KITLG — MAPK14

Text-mined interactions from Literome

Jeong et al., Endocrinology 2003 : Dexamethasone inhibited SCF induced p38 MAPK activation to near-basal levels and induced MAPK phosphatase-1 expression
Hue et al., Immunol Lett 2005 (Melanoma, Experimental) : Furthermore, inhibitors of p38 mitogen activated protein kinase ( MAPK ), such as SB203580, blocked enhanced SCF expression, indicating that p38 MAPK activity is required for IL-18 enhanced SCF production
Qu et al., Mol Cell Biol 1997 : Stem cell factor induction of mitogen activated protein kinase activity was also blocked in Shp-2 mutant cells
Sui et al., Blood 1998 : Wortmannin only inhibits MAPK activation induced by EPO but not that by SCF, suggesting that SCF and EPO may activate MAPK through different pathways, which would facilitate synergy